FAQ

EMA200

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
01220132017

Related topics

Related topics

1 relation

Broader (1)

PD 123319

Related mentions per year

Related mentions per year

1990-2018
1990200020102020
EMA200
PD 123319

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
EMA401 is an old molecule, synthesized by Parke-Davis in the last century and characterized at that time as an AT2R antagonist… (More)
  • figure 1
Is this relevant?
2017
2017
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
Sensory defects associated with small-fiber neuropathy (SFN) can lead to profound disabilities. The relationship between the… (More)
Is this relevant?
2014
2014
Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.
OBJECTIVE The pathobiology of prostate cancer (PCa)-induced bone pain (PCIBP) has both inflammatory and neuropathic components… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2014
2014
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
Individuals infected with the HIV and taking certain antiretroviral drugs to suppress viral replication have a high prevalence of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Small molecule angiotensin II type 2 receptor (ATâ‚‚R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats.
OBJECTIVE Neuropathic pain is an area of unmet clinical need. The objective of this study was to define the pharmacokinetics… (More)
Is this relevant?